T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro

  • Baranovich T
  • Wong S
  • Armstrong J
  • et al.
328Citations
Citations of this article
269Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Several novel anti-influenza compounds are in various phases of clinical development. One of these, T-705 (favipiravir), has a mechanism of action that is not fully understood but is suggested to target influenza virus RNA-dependent RNA polymerase. We investigated the mechanism of T-705 activity against influenza A (H1N1) viruses by applying selective drug pressure over multiple sequential passages in MDCK cells. We found that T-705 treatment did not select specific mutations in potential target proteins, including PB1, PB2, PA, and NP. Phenotypic assays based on cell viability confirmed that no T-705-resistant variants were selected. In the presence of T-705, titers of infectious virus decreased significantly ( P < 0.0001) during serial passage in MDCK cells inoculated with seasonal influenza A (H1N1) viruses at a low multiplicity of infection (MOI; 0.0001 PFU/cell) or with 2009 pandemic H1N1 viruses at a high MOI (10 PFU/cell). There was no corresponding decrease in the number of viral RNA copies; therefore, specific virus infectivity (the ratio of infectious virus yield to viral RNA copy number) was reduced. Sequence analysis showed enrichment of G→A and C→T transversion mutations, increased mutation frequency, and a shift of the nucleotide profiles of individual NP gene clones under drug selection pressure. Our results demonstrate that T-705 induces a high rate of mutation that generates a nonviable viral phenotype and that lethal mutagenesis is a key antiviral mechanism of T-705. Our findings also explain the broad spectrum of activity of T-705 against viruses of multiple families.

References Powered by Scopus

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

2804Citations
N/AReaders
Get full text

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1247Citations
N/AReaders
Get full text

Broad-spectrum antiviral activity of virazole: 1-β-D-ribofuranosyl-1, 2,4-triazole-3-carboxamide

906Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease

1088Citations
N/AReaders
Get full text

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

862Citations
N/AReaders
Get full text

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

851Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Baranovich, T., Wong, S.-S., Armstrong, J., Marjuki, H., Webby, R. J., Webster, R. G., & Govorkova, E. A. (2013). T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro. Journal of Virology, 87(7), 3741–3751. https://doi.org/10.1128/jvi.02346-12

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25020406080

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 89

60%

Researcher 41

28%

Professor / Associate Prof. 11

7%

Lecturer / Post doc 8

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 46

34%

Biochemistry, Genetics and Molecular Bi... 43

32%

Pharmacology, Toxicology and Pharmaceut... 23

17%

Medicine and Dentistry 22

16%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1
References: 4
Social Media
Shares, Likes & Comments: 49

Save time finding and organizing research with Mendeley

Sign up for free
0